About
HQS Quantum Simulations is a quantum software company that develops quantum algorithms and applications for materials science, chemistry, and pharmaceutical research. It was founded in 2017 by Michael Marthaler, Iris Schwenk, and Konstantin Willeke from the Karlsruhe Institute of Technology. The company specializes in quantum simulations of molecular and material systems that are computationally challenging for classical computers, developing software for drug discovery, catalyst design, battery materials, and chemical process optimization. HQS works with pharmaceutical companies, chemical manufacturers, and materials research organizations. Its algorithms simulate molecular interactions, electronic structures, and chemical reaction pathways, and its platform integrates with existing quantum hardware and classical simulation workflows to bridge current computational chemistry methods and future quantum advantage. The company has established partnerships with quantum hardware providers and major industrial customers. In April 2024, HQS launched HQStage, a modular quantum simulation toolkit covering input, simulation, model analysis, and quantum computing workflows for researchers and developers. In January 2025, HQS received a EUR 2.5M EIC Transition Grant for the HQS-NextNMR project, which is developing a high-precision NMR spectroscopy prediction tool for personalized medicine and biological sample analysis. The tool runs on classical hardware and delivers accuracy superior to existing software.
Quantum Specifications
| Quantum Focus | software |